Mehta, V <br/><br/>
Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Mar 2008 
 - 430-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/sj.clpt.6100304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Central Nervous System--drug effects<br/>Cyclooxygenase 2--metabolism<br/>Cyclooxygenase 2 Inhibitors--metabolism<br/>Female<br/>Humans<br/>Inhibitory Concentration 50<br/>Injections, Intravenous<br/>Isoxazoles--administration & dosage<br/>Male<br/>Middle Aged<br/>Sulfonamides--blood<br/>Time Factors